Several patent litigations have been filed involving mRNA pioneers such as Moderna, Inc. and BioNTech, Inc. (with Pfizer) over the
Continue Reading The Current mRNA/LNP Patent Litigation Landscape
Several patent litigations have been filed involving mRNA pioneers such as Moderna, Inc. and BioNTech, Inc. (with Pfizer) over the…
Continue Reading The Current mRNA/LNP Patent Litigation Landscape
On August 16, 2022, Merck (NYSE: MRK) and Orna Therapeutics each announced that they entered into a collaboration agreement relating…
Continue Reading Merck and Orna Therapeutics Join Forces in Circular RNA Collaboration
On April 13, 2022, the European Commission submitted a proposed regulation on the protection of Geographical Indications for Craft and…
Continue Reading Geographical Indications in the EU: A Step Forward in the Protection of Traditional Artisanal Skills
Introduction
For many start-up companies, the prospect of filing a patent application can be daunting. Even when a company has…
Continue Reading What Do I Need to File a Utility Patent Application?
In light of Elon Musk’s recent offer to buy Twitter, Inc. (“Twitter”) there has been a resurgence in the desire…
Continue Reading Increased Innovation in Decentralized Social Networks Space Spurred By Ownership Uncertainty of Traditional Platforms
Background
The food tech industry has been rapidly growing in recent years with the rise in popularity of alternative (“alt-“)…
Continue Reading Foodtech Pioneer Impossible Foods Sues Competitor Motif for Patent Infringement
In the first major patent infringement lawsuit in the mRNA space, on February 28, 2022, Arbutus Biopharma Corporation (“Arbutus”) and…
Continue Reading Arbutus and Genevant Sue Moderna in First Significant Patent Infringement Lawsuit in the mRNA Space
On February 28, 2022, the Patent Trial and Appeal Board (PTAB) issued a decision in Interference No. 106,115, which granted…
Continue Reading PTAB Sides with Broad in Patent Dispute over CRISPR Gene Editing of Eukaryotic Cells
Generative content is having a moment in the form of non-fungible tokens (NFTs) powered by blockchain platforms. Continued investment and…
Continue Reading Human Creativity v. Machine Autonomy in Identifying Copyright Authors of Generative NFTs
On January 4, 2022, Judge Andrews from the United States District Court for the District of Delaware denied Sarepta Therapeutics,…
Continue Reading Delaware Judge Denies Sarepta Protection Under Hatch-Waxman “Safe Harbor”
We use cookies to enhance your user experience. By continuing to use this site you are giving your consent for us to use cookies. For more information, please see our Privacy Policy.